The screws continue to tighten on compounded bioidentical hormone replacement therapy (cBHRT), the future of which is in peril. We need your help to support a US Senate sign-on letter telling the FDA NOT to limit access to these treatments. Action Alert! A letter being circulated in the Senate by US Senators Tammy Baldwin (D-WI) and Roger Marshall (R-KS) urges the FDA to enact policies that allow patients to continue using compounded bioidentical hormone replacement therapy (cBHRT). Read more.